Actively Recruiting
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Led by Soochow University · Updated on 2025-05-13
400
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
CONDITIONS
Official Title
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent by patient
- Age 65 18 years
- Acute ischemic stroke with matching brain lesion on MR imaging
- Enrollment within 24 hours after onset of stroke symptoms
You will not qualify if you...
- Pregnancy and/or breastfeeding
- Participation in an interventional study
- Patient refusal to participate in the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The first affiliated hospital of soochow university
Suzhou, Jiangsu, China, 215000
Actively Recruiting
Research Team
J
Jianqiang Ni, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here